锦欣生殖(01951.HK)2024中期报告进一步披露有关经营的细节。上半年，锦欣生殖实现收入14.44亿元，同比增长8.2%；实现净利润1.90亿元，下降15%。尽管如此，收入增长的数字显著低于过去3年的增速。2021年、2022年和2023年锦欣生殖收入分别增长了28.34%、28.37%和18.33%；上半年公司毛利率为40.38%，同比下降1.93个百分点，主要由于美国业务扩张招募新医生...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.